Vestal Point Capital’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.9M | Sell |
4,675,000
-76,292
| -2% | -$862K | 2.78% | 10 |
|
|
2025
Q1 | $54.8M | Sell |
4,751,292
-18,708
| -0.4% | -$216K | 3.92% | 6 |
|
|
2024
Q4 | $40.4M | Buy |
4,770,000
+770,000
| +19% | +$6.52M | 2.4% | 14 |
|
|
2024
Q3 | $46.3M | Buy |
4,000,000
+1,700,000
| +74% | +$19.7M | 3.51% | 7 |
|
|
2024
Q2 | $27.1M | Buy |
2,300,000
+1,645,000
| +251% | +$19.4M | 2.02% | 14 |
|
|
2024
Q1 | $7.77M | Buy |
+655,000
| New | +$7.77M | 0.64% | 33 |
|